Skip to main content
Home » Cardiovascular Health » Uniphar Medtech plays a central role in advancing Cardiovascular care in Ireland and beyond
Sponsored

Brendan McConnell MD

M3 Medical Part of Uniphar Medtech

Cardiovascular disease remains one of the most significant health challenges in Ireland, and innovation in this field continues to advance at a pace.


At Uniphar Medtech, we give healthcare providers access to world‑class interventional, diagnostic and monitoring technologies that enhance patient outcomes and support the delivery of safe, effective care.

Cardiology is a major strategic priority for our organisation, and through our specialised businesses — M3 Medical and Cardiac Services — we partner closely with hospitals and global innovators to ensure clinicians can adopt new therapies and procedural techniques that make a meaningful difference at the point of care.

we’re evolving towards a procedural‑centric model that enables physicians to deliver seamless, high‑quality care from the moment vascular access is obtained to final closure

Procedural-centric model

At M3 Medical, we’re evolving towards a procedural‑centric model that enables physicians to deliver seamless, high‑quality care from the moment vascular access is obtained to final closure. By offering a complementary portfolio that spans Access, Navigation, Treatment and Closure, we help clinicians work efficiently across every stage of the procedure.

This complete approach ensures consistency, reliability and confidence when delivering complex cardiovascular interventions. Our strength lies not only in our technologies but in the clinical excellence and support of our team, specialists who stand alongside clinicians in the cath lab, hybrid suite and operating room to help optimise outcomes and advance procedural performance.

What truly differentiates Uniphar Medtech is the combination of clinical insight, technical capability and service excellence that defines everything we do. Across both M3 Medical and Cardiac Services, our teams provide end‑to‑end support through education, case‑based training, in‑theatre guidance and dependable equipment servicing, ensuring the most effective and sustainable delivery of cardiovascular care nationwide.

Future of cardiovascular health

As cardiology continues to evolve toward a future that’s not only minimally invasive but also digitally enabled, we remain committed to investing in the partnerships, technologies and expertise that will shape the next generation of cardiovascular care. By combining global innovation with local procedural support and clinical excellence, Uniphar Medtech is proud to play a leading role in advancing cardiovascular health across Ireland, the UK and Europe.

Next article